Kratom natural pero adictivo...

FDA Warns Against Use of Kratom

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

The FDA is warning patients against using products containing kratom (Mitragyna speciosa), a botanical that some take recreationally or to self-treat opioid addiction. Kratom acts on the same opioid receptors as morphine and "appears to have properties that expose users to the risks of addiction, abuse, and dependence," the agency notes.

Calls to U.S. poison control centers regarding kratom rose tenfold between 2010 and 2015; hundreds of calls are made every year, FDA Commissioner Dr. Scott Gottlieb said in a statement. Side effects of its use include seizures, liver injury, and withdrawal symptoms. The agency knows of 36 kratom-related deaths.

Kratom grows in Thailand, Malaysia, Indonesia, and Papua New Guinea. The FDA banned its importation in 2014, but in the years since, the agency has seized large amounts of kratom-containing dietary supplements.

FDA public health announcement (Free)

FDA commissioner's statement (Free)

Background: Physician's First Watch coverage of 2016 CDC warning on kratom (Free)

Benjamin Hidalgo-Matlock

Skin Care Physicians of Costa Rica

4000-1054

2208-8206

Please excuse the shortness of this message, as it has been sent from a mobile device.